Adlai Nortye Ltd.

Adlai Nortye Ltd.

Healthcare

NASDAQ:ANL · NASDAQ Global Market

Market Cap $544.60M Beta 0.99 P/E (TTM) -3.0
$10.10 -1.07%

-$0.11 today

52W Low $0.88High $17.25

Vol 0.04M · Avg 0.35M

EPS (TTM) -$3.33Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+621.43%

Period High

$16.60

Period Low

$0.88

Latest

$10.10

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
TH

Tharimmune, Inc.

THAR

$139.94M

AP

Apollomics, Inc.

APLM

$18.54M

BL

BioLineRx Ltd.

BLRX

$13.62M

LP

Lipocine Inc.

LPCN

$13.46M

AD

Adaptimmune Therapeutics plc

ADAP

$12.53M

OS

OSR Holdings, Inc.

OSRH

$9.27M

IC

SeaStar Medical Holding Corporation

ICU

$8.84M

AI

Ainos, Inc.

AIMD

$8.83M

GO

GeoVax Labs, Inc.

GOVX

$1.14M

AD

Aditxt, Inc.

ADTX

$425.00

What is the latest ANL filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does ANL have?

Intrinsic Alpha currently shows 20 recent filings for ANL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.